Compounds > 2-pyrrolino-dox
Page last updated: 2024-09-03

2-pyrrolino-dox and Prostatic Neoplasms

2-pyrrolino-dox has been researched along with Prostatic Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nagy, A; Schally, AV1
Halmos, G; Kanashiro, CA; Nagy, A; Schally, AV; Stangelberger, A; Szepeshazi, K1
Arencibia, JM; Groot, K; Halmos, G; Koppán, M; Nagy, A; Plonowski, A; Schally, AV1
Nagy, A; Plonowski, A; Schally, AV; Sun, B; Szepeshazi, K1
Groot, K; Halmos, G; Nagy, A; Plonowski, A; Schally, AV; Sun, B1
Halmos, G; Nagy, A; Plonowski, A; Schally, AV; Sun, B1

Reviews

1 review(s) available for 2-pyrrolino-dox and Prostatic Neoplasms

ArticleYear
Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.
    Biology of reproduction, 2005, Volume: 73, Issue:5

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Doxorubicin; Endometrial Neoplasms; Epithelial Cells; Female; Gonadotropin-Releasing Hormone; Humans; Male; Ovarian Neoplasms; Prostatic Neoplasms; Pyrroles; Receptors, LHRH

2005

Other Studies

5 other study(ies) available for 2-pyrrolino-dox and Prostatic Neoplasms

ArticleYear
Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.
    The Prostate, 2006, Feb-01, Volume: 66, Issue:2

    Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Disease Progression; Doxorubicin; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrroles; Receptors, LHRH; RNA, Messenger; Transplantation, Heterologous; Triptorelin Pamoate

2006
Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice.
    The Prostate, 1999, Feb-01, Volume: 38, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Doxorubicin; Drug Delivery Systems; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Mice, Nude; Models, Chemical; Polymerase Chain Reaction; Prostatic Neoplasms; Pyrroles; Receptors, LHRH; Transplantation, Heterologous; Tumor Cells, Cultured

1999
Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
    Cancer research, 1999, Apr-15, Volume: 59, Issue:8

    Topics: Androgens; Animals; Antibiotics, Antineoplastic; Doxorubicin; Gene Expression; Humans; Lymphatic Metastasis; Male; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Prostatic Neoplasms; Pyrroles; Receptors, Somatostatin; Somatostatin; Transplantation, Heterologous; Tumor Cells, Cultured

1999
In vivo inhibition of PC-3 human androgen-independent prostate cancer by a targeted cytotoxic bombesin analogue, AN-215.
    International journal of cancer, 2000, Nov-15, Volume: 88, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Bombesin; Carboxylic Ester Hydrolases; Doxorubicin; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Pyrroles; Receptors, Bombesin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2000
Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238.
    International journal of oncology, 2002, Volume: 20, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Cell Division; Cytotoxins; Doxorubicin; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Octreotide; Prostatic Neoplasms; Pyrroles; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Treatment Outcome; Tumor Cells, Cultured

2002